Navigation Links
Genzyme Announces Results of Clinical Trials Investigating Powder,Form of Sevelamer Carbonate

CAMBRIDGE, Mass., June 18, 2007 /PRNewswire-FirstCall/ -- Genzyme Corp. today announced the results of two new studies comparing a powder form of Renvela (sevelamer carbonate) to Renagel tablets (sevelamer hydrochloride), including one trial in which patients received the powder form three times per day, and one in which it was administered once per day.

Genzyme is developing Renvela in powder form to provide an additional option for patients with chronic kidney disease in managing their phosphate levels. A New Drug Application for Renvela tablets is already on file with the FDA, and previous studies have shown that the tablet formulation provides equivalent phosphate control to Renagel in patients on dialysis and significant phosphorus control in patients with chronic kidney disease who are not on dialysis. Today's results are the first from trials comparing the efficacy of the powder form of Renvela to Renagel tablets.

In the first powder trial, patients treated with the powder form of Renvela three times per day experienced equivalent phosphorus control to patients treated with Renagel tablets three times per day. As a result, this trial successfully met its primary endpoint.

In the second trial, patients dosed with the powder form of Renvela once per day and those treated with Renagel tablets three times per day achieved statistically significant reductions in serum phosphorus, with both groups reaching target levels for phosphorus control outlined in the K/DOQI treatment guidelines. Phosphorus levels in the Renagel arm (4.6 mg/dL) were lower than those in the Renvela arm (5.3 mg/dL), and this trial did not achieve its primary endpoint of demonstrating non-inferiority of Renvela powder dosed once per day to Renagel tablets dosed three times per day.

In both trials, the safety profile of Renvela was consistent with the previous clinical experience of patients on dialysis using Ren
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
2. Genzyme Announces Results of Clinical Trial of Hylastan
3. Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate
4. Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
5. Genzyme Announces Successful Completion of Study Investigating Sevelamer Carbonate in Patients With Chronic Kidney Disease
6. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
7. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
9. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
10. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
11. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:8/21/2014)... HAMBURG, Germany , Aug. 21, 2014 /PRNewswire/ ... collaborating with Deutsches Elektronen-Synchrotron ( DESY ), a leading ... to speed up management and storage of massive volumes ... Analytics architecture based on IBM software defined technology ... data at peak performance and help scientists worldwide gain ...
(Date:8/21/2014)... Aug. 21, 2014  ACI Clinical ( www.aciclinical.com ... Data Monitoring Committees. Using this solution, ... over industry standard costs and receive the same ... in committee services. Leveraging a decade ... contracting, charter development, statistical programming and meeting facilitation), ...
(Date:8/21/2014)... Aug. 21, 2014 CVS Caremark Corporation (NYSE: ... Reference Yields and consideration payable in connection with its previously ... 7, 2014 for (1) any and all of its 6.250% ... (2) up to a maximum amount of its 6.125% Senior ... Senior Notes due 2017 (collectively, the "Maximum Tender Offer Notes" ...
Breaking Medicine Technology:DESY and IBM Develop Big Data Architecture for Science 2DESY and IBM Develop Big Data Architecture for Science 3ACI Clinical: Innovation and Savings in Data Safety Monitoring Committees 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 3CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 4CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 5CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 6
... EAST BRUNSWICK, N.J., Nov. 3, 2011 Savient Pharmaceuticals, Inc. ... the three and nine months ended September 30, 2011, which ... KRYSTEXXA® (pegloticase). Savient ended the quarter with $202.7 million in ... the quarter.  For the third quarter of 2011, the Company ...
... LOS ANGELES, Nov. 3, 2011 MedInformatix, a ... industry, announced today it has completed certification with ... certification, the MedInformatixVersion 7.5 prescriber software connected through ... exchange prescription information electronically through the Surescripts secure ...
Cached Medicine Technology:Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 2Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 3Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 4Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 5Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 6Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 7MedInformatix Earns Surescripts® Prescription Routing Certification 2MedInformatix Earns Surescripts® Prescription Routing Certification 3
(Date:8/21/2014)... Aug. 21, 2014 (HealthDay News) -- Black mothers are ... and here,s one possible reason why: Hospitals in neighborhoods ... than those in areas with more white residents, a ... breast-feeding are much less common in medical centers where ... the U.S. Centers for Disease Control and Prevention reported ...
(Date:8/21/2014)... 21, 2014 The W. Montague ... and a national voice in the elimination of ... disparities during the 112th National Medical Association’s (NMA) ... included: , John Ruffin, Ph.D, former Director of ... Disparities, whose life-long career and innovations have had ...
(Date:8/21/2014)... communities do not routinely screen women for intimate ... and public health researchers. Rural women who are ... they seek help., "Rural health care providers are ... McCall-Hosenfeld, a primary care physician and assistant professor ... College of Medicine. "However, in rural settings, it ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 The ... Market by Pollutant Control System (FGD, DeNOx, Particulate ... Iron & Steel, Chemical & Others) - Global ... the global industrial flue gas treatment systems & ... global market size in terms of value. The ...
(Date:8/21/2014)... August 21, 2014 The Swedish-American ... year's conference will focus on the Future of ... research, innovation and commercialization. , With the mission ... combines the worlds' of business and science. "Over ... recognized Summit, gathering a diverse community with representatives ...
Breaking Medicine News(10 mins):Health News:Racial Disparities in Breast-Feeding May Start With Hospitals, Study Suggests 2Health News:W. Montague Cobb/NMA Health Institute Honors Three Outstanding Leaders in Health Disparities 2Health News:Primary care physicians can be critical resource for abused women in rural areas 2Health News:Industrial Flue Gas Treatment Systems Market Estimated to Worth $59, 546.7 Million by 2019 – Report by MarketsandMarkets 2Health News:Industrial Flue Gas Treatment Systems Market Estimated to Worth $59, 546.7 Million by 2019 – Report by MarketsandMarkets 3Health News:Industrial Flue Gas Treatment Systems Market Estimated to Worth $59, 546.7 Million by 2019 – Report by MarketsandMarkets 4Health News:The Tenth Swedish-American Life Science Summit, takingplace in Stockholm, Sweden, August 20-22nd, will focus on The Future of Medicine 2
... biomarker that enables close to 98 percent accuracy in predicting ... study is published in the March 1 issue of Clinical ... Research. , When cancer spreads beyond a solid tumor, ... cannot be identified by conventional imaging methods such as CT ...
... release is available in Spanish . , ... of the University of Navarra have discovered the molecular ... for primary biliary cirrhosis, which combines two substances in ... from either substance separately. The discovery involved the role ...
... rising consumer demand for organic milk, BROOMFIELD, Colo., ... company, today announced that the brand,expanded its farmer partner ... nearly 450 family farmer partners in 22 states across ... to becoming certified,organic., "Family farms have been at ...
... a Sense of Purpose, WASHINGTON, Feb. 27 ... during Operation Iraqi,Freedom and Operation Enduring Freedom (OIF/OEF), will ... Winter Sports Clinic in,Snowmass Village, March 30 - April ... physical, social, and emotional,well-being of the veterans who participate ...
... Inc. ("Versus" or the "Company") announced revenues of,$1,426,000 ... 2008, a 26%,increase over revenues of $1,133,000 for ... revenues can vary significantly depending upon the,timing of ... in any one quarter are not necessarily indicative ...
... Gains Momentum, Physicians Trumpet, the Value of ePrescribing in Significantly ... ... Care, DETROIT, Feb. 27 Efforts to expand the use ... ePrescribing receives high marks from constituents,whose opinion about the technology may ...
Cached Medicine News:Health News:New blood marker may predict prostate cancer spread 2Health News:New blood marker may predict prostate cancer spread 3Health News:Cause of effectiveness discovered for a cirrhosis treatment useful in 40 percent of patients 2Health News:Horizon Organic(R) Family Farmer Network Grows by Nearly 35 Percent 2Health News:World's Largest Disabled Ski Clinic at Snowmass, Colo. 2Health News:Versus Technology Announces First Quarter Results 2Health News:Versus Technology Announces First Quarter Results 3Health News:Versus Technology Announces First Quarter Results 4Health News:Versus Technology Announces First Quarter Results 5Health News:Versus Technology Announces First Quarter Results 6Health News:Prescription for Change: New Survey Shows ePrescribing Connecting with its Biggest Skeptics ... Physicians 2Health News:Prescription for Change: New Survey Shows ePrescribing Connecting with its Biggest Skeptics ... Physicians 3Health News:Prescription for Change: New Survey Shows ePrescribing Connecting with its Biggest Skeptics ... Physicians 4Health News:Prescription for Change: New Survey Shows ePrescribing Connecting with its Biggest Skeptics ... Physicians 5Health News:Prescription for Change: New Survey Shows ePrescribing Connecting with its Biggest Skeptics ... Physicians 6Health News:Prescription for Change: New Survey Shows ePrescribing Connecting with its Biggest Skeptics ... Physicians 7
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: